Feed BOLD
Summary
56 / 100 · Bulios Score
Valuation 100Growth -Profitability -Quality 0Debt 100Stability 31
What speaks for it
- It has no debt and holds $20.2M in cash.
- The price moves less than the market (beta 0.38).
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
Revenue (USD)
20212022202320242025
Diluted EPS (USD)
2021202220232024202520262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $64.0M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $72.6M
Debt $0.00
Free cash flow over 12 months -$56.7M
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 13
- Sell 1
No analyst has published a price target.
30% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.